alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies – topic of research paper in Clinical medicine.
The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set | PLOS ONE
Deconstructing the molecular portrait of basal-like breast cancer
![PDF] Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/033bbabb417eeef47ec5346cab08e8b3afa8c698/6-Figure1-1.png "PDF] Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. | Semantic Scholar")
PDF] Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies. | Semantic Scholar
How different are luminal A and basal breast cancers? - Bertucci - 2009 - International Journal of Cancer - Wiley Online Library
Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray Analysis | bioRxiv
IJMS | Free Full-Text | The Proliferative and Apoptotic Landscape of Basal-like Breast Cancer
MCF-10A cells overexpressing αB-crystallin form invasive mammary... | Download Scientific Diagram
PDF) Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists | Sunil Badve - Academia.edu
Molecular insights on basal-like breast cancer
CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer | Oncogene
Cancers | Free Full-Text | Plant Derived Bioactive Compounds, Their Anti- Cancer Effects and In Silico Approaches as an Alternative Target Treatment Strategy for Breast Cancer: An Updated Overview
Another review on triple negative breast cancer. Are we on the right way towards the exit from the labyrinth? - ScienceDirect
αB-crystallin expression in breast cancer is associated with brain metastasis | npj Breast Cancer
Frontiers | Recent Advances in the Treatment of Breast Cancer
Identification of Key Genes Potentially Related to Triple Receptor Negative Breast Cancer by Microarray Analysis | bioRxiv
![PDF] The Proliferative and Apoptotic Landscape of Basal-like Breast Cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f8b6beaad7d0b64a2a9a9648ba4fe29ec77304b0/3-Figure1-1.png "PDF] The Proliferative and Apoptotic Landscape of Basal-like Breast Cancer | Semantic Scholar")
PDF] The Proliferative and Apoptotic Landscape of Basal-like Breast Cancer | Semantic Scholar
The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set | PLOS ONE
Triple-Negative Breast Cancer
IJMS | Free Full-Text | The Proliferative and Apoptotic Landscape of Basal-like Breast Cancer
The Proliferative and Apoptotic Landscape of Basal-like Breast Cancer. - Abstract - Europe PMC
Review Article Proteomics and its applications in breast cancer
Pharmaceutics | Free Full-Text | Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer
IJMS | Free Full-Text | The Proliferative and Apoptotic Landscape of Basal-like Breast Cancer
How different are luminal A and basal breast cancers? - Bertucci - 2009 - International Journal of Cancer - Wiley Online Library
Impact of Basal-Like Breast Carcinoma Determination for a More Specific Therapy
Proteomics of Breast Cancer - Molecular & Cellular Proteomics
Comprehensive characterization of claudin-low breast tumors reflects the impact of the cell-of-origin on cancer evolution | Nature Communications
